Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global HMOs Market Status and Forecast (2016-2027)
  • 1.3.2 Global HMOs Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global HMOs Supply by Company

• 2.1 Global HMOs Sales Value by Company
• 2.2 HMOs Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional HMOs Market Status by Category

• 3.1 HMOs Category Introduction
  • 3.1.1 Neutral HMOs
  • 3.1.2 Acidic HMOs
• 3.2 Global HMOs Market by Category
• 3.3 North America: by Category
• 3.4 Europe: by Category
• 3.5 Asia Pacific: by Category
• 3.6 Central & South America: by Category
• 3.7 Middle East & Africa: by Category

4 Global and Regional HMOs Market Status by End User/Segment

• 4.1 HMOs Segment by End User/Segment
  • 4.1.1 Food Industry
  • 4.1.2 Laboratory Research
• 4.2 Global HMOs Market by End User/Segment
• 4.3 North America: by End User/Segment
• 4.4 Europe: by End User/Segment
• 4.5 Asia Pacific: by End User/Segment
• 4.6 Central & South America: by End User/Segment
• 4.7 Middle East & Africa: by End User/Segment

5 Global HMOs Market Status by Region

• 5.1 Global HMOs Market by Region
• 5.2 North America HMOs Market Status
• 5.3 Europe HMOs Market Status
• 5.4 Asia Pacific HMOs Market Status
• 5.5 Central & South America HMOs Market Status
• 5.6 Middle East & Africa HMOs Market Status

6 North America HMOs Market Status

• 6.1 North America HMOs Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe HMOs Market Status

• 7.1 Europe HMOs Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific HMOs Market Status

• 8.1 Asia Pacific HMOs Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America HMOs Market Status

• 9.1 Central & South America HMOs Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa HMOs Market Status

• 10.1 Middle East & Africa HMOs Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global HMOs Market Forecast by Category and by End User/Segment

• 12.1 Global HMOs Sales Value Forecast (2022-2027)
• 12.2 Global HMOs Forecast by Category
• 12.3 Global HMOs Forecast by End User/Segment

13 Global HMOs Market Forecast by Region/Country

• 13.1 Global HMOs Market Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 ZuChem
  • 14.1.1 Company Information
  • 14.1.2 HMOs Product Introduction
  • 14.1.3 ZuChem HMOs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 Jennewein Biotechnologie
  • 14.2.1 Company Information
  • 14.2.2 HMOs Product Introduction
  • 14.2.3 Jennewein Biotechnologie HMOs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 Inbiose
  • 14.3.1 Company Information
  • 14.3.2 HMOs Product Introduction
  • 14.3.3 Inbiose HMOs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Glycom
  • 14.4.1 Company Information
  • 14.4.2 HMOs Product Introduction
  • 14.4.3 Glycom HMOs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 Dextra Laboratories
  • 14.5.1 Company Information
  • 14.5.2 HMOs Product Introduction
  • 14.5.3 Dextra Laboratories HMOs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 Abbott
  • 14.6.1 Company Information
  • 14.6.2 HMOs Product Introduction
  • 14.6.3 Abbott HMOs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.6.4 SWOT Analysis

...

15 Conclusion

16 Methodology

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global HMOs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global HMOs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Neutral HMOs
Acidic HMOs

Segmented by End User/Segment
Food Industry
Laboratory Research

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
ZuChem
Jennewein Biotechnologie
Inbiose
Glycom
Dextra Laboratories
Abbott